In human neoplasia, PD-L1 is reported to be expressed by tumor cells, whereas PD-1 is generally expressed by tumor-infiltrating lymphocytes (TIL), and their interaction negatively regulates the adaptive antitumor immune response [10]. Here, PDCD1 is linked to neoplasm.